Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,622 | -7,417 | -4,817 | -2,463 | -9,103 |
| Depreciation Amortization | 142 | 227 | -14 | -182 | 9 |
| Accounts receivable | -214 | -181 | -220 | -223 | -149 |
| Accounts payable and accrued liabilities | 1,423 | 208 | 383 | 238 | -571 |
| Other Working Capital | 986 | -186 | -43 | -180 | -748 |
| Other Operating Activity | -189 | 1,103 | 727 | 554 | 1,321 |
| Operating Cash Flow | $-8,474 | $-6,246 | $-3,984 | $-2,256 | $-9,241 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 15,594 | 12,265 | 9,565 | 307 | -6,000 |
| PPE Investments | -159 | -160 | -154 | -2 | -770 |
| Purchase Of Investment | -26,541 | -25,132 | -21,839 | -19,445 | -2,246 |
| Investing Cash Flow | $-11,106 | $-13,027 | $-12,428 | $-19,140 | $-9,016 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | N/A | 41,856 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $41,856 |
| Beginning Cash Position | 23,736 | 23,736 | 23,736 | 23,736 | 137 |
| End Cash Position | 4,156 | 4,463 | 7,324 | 2,340 | 23,736 |
| Net Cash Flow | $-19,580 | $-19,273 | $-16,412 | $-21,396 | $23,599 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,474 | -6,246 | -3,984 | -2,256 | -9,241 |
| Capital Expenditure | -159 | -160 | -154 | -2 | -770 |
| Free Cash Flow | -8,633 | -6,406 | -4,138 | -2,258 | -10,011 |